The Exchange had sought clarification from Wockhardt with respect to news appearing in moneycontrol website & CNBCTV18 on September 9, 2015 titled ‘Wockhardt shares rise 5% on USFDA nod for alzheimer drug.’ Wockhardt response is enclosed.
The above information is a part of company’s filings submitted to BSE.